VPS4A and hepatocellular carcinoma: Thus, exosomal β-catenin could be used to predict the prognosis of HCC patients because of the higher level of exosomal β-catenin that the metastasis patients own, and VPS4A could regulate the localization of β-catenin, which may work as a target to treat HCC.